Top

BMC Public Health

Published in:

Open Access 01-12-2024 | COVID-19 | Research

Excess non-COVID-19 mortality in Norway 2020–2022

Authors: Guttorm Raknes, Stephanie Jebsen Fagerås, Kari Anne Sveen, Pétur Benedikt Júlíusson, Marianne Sørlie Strøm

Published in: BMC Public Health | Issue 1/2024

Abstract

Background

Causes of death other than COVID-19 seem to contribute significantly to the excess mortality observed during the 2020–2022 pandemic. In this study, we explore changes in non-COVID-19 causes of death in Norway during the COVID-19 pandemic from March 2020 to December 2022.

Methods

We performed a population-based cross-sectional study on data from the Norwegian Cause of Death Registry. All recorded deaths from 1st January 2010 to 31st December 2022 were included. The main outcome measures were the number of deaths and age-standardised death rate (ASMR) per 100000 population from the major cause of death groups in 2020, 2021 and 2022. The predicted number of deaths and ASMRs were forecasted with a 95% prediction interval constructed from a general linear regression model based on the corresponding number of deaths and rates from the preceding ten prepandemic years (2010–2019). We also examined whether there were deviations from expected seasonality in the pandemic period based on prepandemic monthly data from 2010–2019. The cumulative number of deaths and ASMR were estimated based on monthly mortality data.

Results

There was significant excess mortality (number of deaths) in 2021 and 2022 for all causes (3.7% and 14.5%), for cardiovascular diseases (14.3% and 22.0%), and for malignant tumours in 2022 (3.5%). In terms of ASMR, there was excess mortality in 2021 and 2022 for all causes (2.9% and 13.7%), and for cardiovascular diseases (16.0% and 25,8%). ASMR was higher than predicted in 2022 for malignant tumours (2.3%). There were fewer deaths than predicted from respiratory diseases (except COVID-19) in 2020 and 2021, and from dementia in 2021 and 2022. From March 2020 to December 2022, there were cumulatively 3754 (ASMR 83.8) more non-COVID-19 deaths than predicted, of which 3453 (ASMR: 79.6) were excess deaths from cardiovascular disease, 509 (ASMR 4.0) from malignant tumours. Mortality was lower than predicted for respiratory diseases (-1889 (ASMR: -44.3)), and dementia (-530 (ASMR -18.5)).

Conclusions

There was considerable excess non-COVID-19 mortality in Norway from March 2020 until December 2022, mainly due to excess cardiovascular deaths. For respiratory diseases and dementia, mortality was lower than predicted.

Available only for authorised users

Haug M. Forventa levealder falt i. 2022. https://www.ssb.no/befolkning/fodte-og-dode/statistikk/dode/artikler/forventa-levealder-falt-i-2022. Accessed Oct 2023.

Alicandro G, La Vecchia C, Islam N, Pizzato M. A comprehensive analysis of all-cause and cause-specific excess deaths in 30 countries during 2020. Eur J Epidemiol. 2023. https://doi.org/10.1007/s10654-023-01044-x.

Harrison D. What is driving all cause excess mortality? BMJ. 2022;376:o100. https://doi.org/10.1136/bmj.o100.CrossRefPubMed

Saqib MAN, Siddiqui S, Qasim M, Jamil MA, Rafique I, Awan UA, Ahmad H, Afzal MS. Effect of COVID-19 lockdown on patients with chronic diseases. Diabetes Metab Syndr. 2020;14(6):1621–3. https://doi.org/10.1016/j.dsx.2020.08.028.CrossRefPubMedPubMedCentral

Amiri A. Role of social distancing in tackling COVID-19 during the first wave of pandemic in Nordic region: Evidence from daily deaths, infections and needed hospital resources. Int J Nurs Sci. 2021;8:145–51. https://doi.org/10.1016/j.ijnss.2021.03.010.CrossRefPubMedPubMedCentral

ICD-11 Reference Guide: 2.15.2 Data source: The international form of Medical Certificate of Cause of Death (MCCD) [https://icdcdn.who.int/icd11referenceguide/en/html/index.html#data-source-the-international-form-of-medical-certificate-of-cause-of-death-mccd]. Accessed 11 Oct 2023.

Norwegian Institute of Public Health: Elektronisk dødsmelding. [https://www.fhi.no/hn/helseregistre-og-registre/dodsarsaksregisteret/elektronisk-dodsmelding/]. Accessed 11 Oct 2023.

Federal Institute for Drugs and Medical Devices: Iris software. [https://www.bfarm.de/EN/Code-systems/Collaboration-and-projects/Iris-Institute/Iris-software/_node.html]. Accessed 11 Oct 2023.

Lu TH. Using ACME (automatic classification of medical entry) software to monitor and improve the quality of cause of death statistics. J Epidemiol Community Health. 2003;57:470–4711. https://doi.org/10.1136/jech.57.6.470.CrossRefPubMedPubMedCentral

10.

World Health Organization. Rules and guidelines for mortality and morbidity coding. In: International statistical classification of diseases and related health problems: instruction manual 10th revision. Volume 2. 5th edition. Geneva: World Health Organization; 2016:31–38.

11.

Eurostat: Revision of the European Standard Population: report of Eurostat’s task force – 2013 edition. [https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-13-028]. Accessed Oct 2023.

12.

13.

Knudsen AKS, Madsen C, Forthun I, Tvedten HM, Dahl J, Lyngstad TM, Strøm MS, Fagerås SJ, Tapia G, Schwinger C, Aavitsland P, Paulsen TH, Kløvstad H, Baravelli C, Sveen KA, Zahl PH, Juliusson PB, Gulseth HL. Dødelighet i Norge under koronapandemien 2020–2022. Oslo: Folkehelseinstituttet; 2023.

14.

Lee WE, Woo Park S, Weinberger DM, Olson D, Simonsen L, Grenfell BT, Viboud C. Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022. Elife. 2023;12:e77562. https://doi.org/10.7554/eLife.77562.CrossRefPubMedPubMedCentral

15.

Silverio-Murillo A. Balmori de la Miyar JR, Martínez-Alfaro A: Non-COVID-19 deaths in times of pandemic. J Public Health (Oxf). 2023;45(2):e196–203. https://doi.org/10.1093/pubmed/fdac115.CrossRefPubMed

16.

Socialstyrelsen. Statistikdatabas för dödsorsaker. [https://sdb.socialstyrelsen.se/if_dor/val.aspx]. Accessed Oct 2023.

17.

Sundhetsdatastyrelsen. Dødsårsager. [https://www.esundhed.dk/Emner/Hvad-doer-vi-af/Doedsaarsager]. Accessed Oct 2023.

18.

Fairman KA, Goodlet KJ, Rucker JD, Zawadzki RS. Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations. BMJ Open. 2021;11:e050361. https://doi.org/10.1136/bmjopen-2021-050361.CrossRefPubMed

19.

Slungård GF, Forster R, Nguyen TT, Eriksen SHW, Altreuther M, Berge VB, Bjørnstad J, Bønaa KH, Fjærtoft H, Geiran O, Govatsmark RES, Grundtvig M, Halle KK, Hovland S, Indredavik B, Ingul CB, Kramer-Johansen J, Nilsen LH, Rotevatn S, Schuster PM, Slind EK, Tjelmeland I, Torsvik E, Vikan KK, Kvåle R. Hjerte- og karregisteret Rapport for 2012–2021. Bergen: Folkehelseinstituttet; 2022.

20.

Raknes G, Strøm MS, Sulo G, Øverland S, Roelants M, Juliusson PB. Lockdown and non-COVID-19 deaths: cause-specific mortality during the first wave of the 2020 pandemic in Norway: a population-based register study. BMJ Open. 2021;11:e050525. https://doi.org/10.1136/bmjopen-2021-050525.CrossRefPubMed

21.

Fedeli U, Amidei CB, Casotto V, Schievano E, Zoppini G. Excess diabetes-related deaths: The role of comorbidities through different phases of the COVID-19 pandemic. Nutr Metab Cardiovasc Dis. 2023;33:1709–15. https://doi.org/10.1016/j.numecd.2023.05.028.CrossRefPubMed

22.

Lopez-Doriga Ruiz P, Gunnes N, Michael Gran J, Karlstad Ø, Selmer R, Dahl J, Bøås H, Aubrey White R, Christine Hofman A, Hessevik Paulsen T, Viksmoen Watle S, Hylen Ranhoff A, Bukholm G, Løvdal Gulseth H, Tapia G. Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway. Vaccine. 2023;41:323–32. https://doi.org/10.1016/j.vaccine.2022.10.085.CrossRefPubMed

23.

Raknes G, Strøm MS. Dødsårsaker i Sverige og Noreg 2010–2020. [https://www.fhi.no/op/dodsarsaksregisteret/dodsarsaker-i-sverige-og-noreg-20102020/]. Accessed Oct 2023.

Title: Excess non-COVID-19 mortality in Norway 2020–2022
Authors: Guttorm Raknes
Stephanie Jebsen Fagerås
Kari Anne Sveen
Pétur Benedikt Júlíusson
Marianne Sørlie Strøm
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: COVID-19
Dementia
Dementia
Published in: BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-023-17515-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excess non-COVID-19 mortality in Norway 2020–2022

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Changes in adolescents’ daily-life solitary experiences during the COVID-19 pandemic: an experience sampling study

A rapid review of opportunities and challenges in the implementation of social prescription interventions for addressing the unmet needs of individuals living with long-term chronic conditions

Correction to: Factors related to increased alcohol misuse by students compared to non-students during the first Covid-19 lockdown in France: the confins study

Knowledge, compliance, and challenges in anti-malarial products usage: a systematic review of at-risk communities for zoonotic malaria

Development of a survey tool to assess the environmental determinants of health-enabling food retail practice in Aboriginal and Torres Strait Islander communities of remote Australia

Association of filial attitude, filial behavior and death literacy: implications for development of death system in Guangdong-Hong Kong-Macao Greater Bay Area of China